Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1978;58:825-836

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaasch, W. H.
Right arrow Articles by Levine, H. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaasch, W. H.
Right arrow Articles by Levine, H. J.

Circulation, Vol 58, 825-836, Copyright © 1978 by American Heart Association


ARTICLES

Chronic aortic regurgitation: the effect of aortic valve replacement on left ventricular volume, mass and function

WH Gaasch, CW Andrias and HJ Levine

Serial echocardiographic left ventricular (LV) studies were performed in 19 patients before (preop) and after (postop) aortic valve replacement (AVR) for chronic aortic regurgitation (AR); the effect of AVR on LV volume, mass and function was determined from the echocardiographic data. In the 12 patients who were considered to have successful surgical results, the average LV end-diastolic dimension fell from a preop value of 6.9 +/- 0.2 cm to 5.5 +/- 0.2 cm (P less than 0.01) at the time of the early postop study (seven to 10 days). Muscle cross-sectional area (CSA) derived from dimension and wall thickness data was used as an index of LV muscle mass (preop CSA = 26 +/- 1.3 cm2); CSA was unchanged at the early postop study, but subsequently fell to near normal within six months after AVR (20 +/- 1 cm2, P less than 0.01). There was a trend toward improvement in systolic performance by the late postop studies (12+ months). In two out of three patients with postop paravalvular AR, LV dimension increased after an initial fall. Four patients without paravalvular AR failed to show a significant reduction in LV dimension in the postop studies. In this group the preop studies showed a tendency toward a large end-diastolic dimension and decreased fractional shortening, but the single preop parameter which differentiated these four from the successfully treated group was an end-diastolic radius-to-wall thickness (R/Th) ratio greater than or equal to 4. Thus, successful AVR for chronic AR results in the normalization of LV volume and a decrease in LV muscle mass to near normal. The R/Th ratio has important prognostic value which appears to be independent of fractional shortening in some patients with chronic AR.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. L. Brown, H. V. Schaff, R. M. Suri, L. Zhuo, T. M. Sundt, J. A. Dearani, R. C. Daly, and T. A. Orszulak
Indexed Left Ventricular Dimensions Best Predict Survival After Aortic Valve Replacement in Patients With Aortic Valve Regurgitation
Ann. Thorac. Surg., April 1, 2009; 87(4): 1170 - 1176.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
2006 WRITING COMMITTEE MEMBERS, R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
Circulation, October 7, 2008; 118(15): e523 - e661.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., September 23, 2008; 52(13): e1 - e142.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): e1 - e148.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. O. Bonow, B. A. Carabello, K. Chatterjee, A. C. de Leon Jr, D. P. Faxon, M. D. Freed, W. H. Gaasch, B. W. Lytle, R. A. Nishimura, P. T. O'Gara, et al.
ACC/AHA 2006 Practice Guidelines for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) Developed in Collaboration With the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 598 - 675.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Scognamiglio, C. Negut, M. Palisi, G. Fasoli, and S. Dalla-Volta
Long-term survival and functional results after aortic valve replacement in asymptomatic patients with chronic severe aortic regurgitation and left ventricular dysfunction
J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1025 - 1030.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. F. Ungacta, V. G. Davila-Roman, M. J. Moulton, B. P. Cupps, P. Moustakidis, D. S. Fishman, R. Actis, B. A. Szabo, D. Li, N. T. Kouchoukos, et al.
MRI-Radiofrequency Tissue Tagging in Patients With Aortic Insufficiency Before and After Operation
Ann. Thorac. Surg., April 1, 1998; 65(4): 943 - 950.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Borer, C. Hochreiter, E. McM. Herrold, P. Supino, M. Aschermann, D. Wencker, R. B. Devereux, M. J. Roman, M. Szulc, P. Kligfield, et al.
Prediction of Indications for Valve Replacement Among Asymptomatic or Minimally Symptomatic Patients With Chronic Aortic Regurgitation and Normal Left Ventricular Performance
Circulation, February 17, 1998; 97(6): 525 - 534.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Klodas, M. Enriquez-Sarano, A. J. Tajik, C. J. Mullany, K. R. Bailey, and J. B. Seward
Surgery for Aortic Regurgitation in Women: Contrasting Indications and Outcomes Compared With Men
Circulation, November 15, 1996; 94(10): 2472 - 2478.
[Abstract] [Full Text]


Home page
NEJMHome page
R. Scognamiglio, S. H. Rahimtoola, G. Fasoli, S. Nistri, and S. D. Volta
Nifedipine in Asymptomatic Patients with Severe Aortic Regurgitation and Normal Left Ventricular Function
N. Engl. J. Med., September 15, 1994; 331(11): 689 - 694.
[Abstract] [Full Text]


Home page
JAMAHome page
R. E. Schmieder, F. H. Messerli, G. Garavaglia, and B. Nunez
Glomerular Hyperfiltration Indicates Early Target Organ Damage in Essential Hypertension
JAMA, December 5, 1990; 264(21): 2775 - 2780.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
P. K. Hoshino and W. H. Gaasch
When to Intervene in Chronic Aortic Regurgitation
Arch Intern Med, February 1, 1986; 146(2): 349 - 352.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
S. H. RAHIMTOOLA
The Need for Cardiac Catheterization and Angiography in Valvular Heart Disease is NotDisproven
Ann Intern Med, September 1, 1982; 97(3): 433 - 439.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
A. Agatston, S. Rubler, T. Abenavoli, S. Kaye, and M. Dolgin
Comparative Study of the Echocardiographic Findings in Hypertensive and Nonhypertensive Cardiomyopathy
Angiology, January 1, 1982; 33(1): 17 - 32.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
J. ROSS Jr.
Left Ventricular Function and the Timing of Surgical Treatment in Valvular Heart Disease
Ann Intern Med, April 1, 1981; 94(4_Part_1): 498 - 504.
[Abstract] [PDF]


Home page
Arch SurgHome page
C. A. Peter and R. H. Jones
Radionuclide Measurements of Left Ventricular Function: Their Use in Patients With Aortic Insufficiency
Arch Surg, November 1, 1980; 115(11): 1348 - 1352.
[Abstract] [PDF]